About APOSAN
APOSAN is a company. It operates as a Direct-to-Consumer (D2C). The company has 656 employees as of April 05, 2024. APOSAN offers products and services including APOSAN ®.
- Employees 656 as on 05 Apr, 2024
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Social
Locked
- Legal Name Rusan Pharma Ltd.
- Jurisdiction Mumbai, Maharashtra, India
-
Annual Revenue
$36.61 M (USD)0.17as on Mar 31, 2022
-
Net Profit
$6.14 M (USD)-33.95as on Mar 31, 2022
-
EBITDA
$9.48 M (USD)-20.66as on Mar 31, 2022
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
656
as on Apr 05, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of APOSAN
APOSAN offers a comprehensive portfolio of products and services, including APOSAN ®.
Apomorphine injection for managing Parkinson’s disease symptoms.
Funding Insights of APOSAN
Detailed funding history for APOSAN
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by APOSAN
Investment portfolio details for APOSAN
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - APOSAN
Detailed financials for APOSAN
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Aposan Comparisons
Peer comparison for APOSAN
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of APOSAN
Detailed competitors of APOSAN
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Aposan
Complete news archive for APOSAN
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about APOSAN
As of Apr 05, 2024, the latest employee count at APOSAN is 656.
Annual revenue of APOSAN is $36.61M as on Mar 31, 2022.
APOSAN, managed by Rusan Pharma Ltd., is dedicated to providing treatment for Parkinsons disease through its primary product, APOSAN , an Apomorphine injection. It is used for managing motor fluctuations in patients with Parkinsons disease not sufficiently controlled by oral medications. The company operates in the healthcare sector, specifically targeting neurological disorders with innovative pharmaceutical solutions. Support services like the APOSAN Hope Program and nurse coordination are also provided to assist patients and caregivers in India.
APOSAN offers APOSAN ®.